Erin Lyons Matiello(@ErinMatiello) 's Twitter Profile Photo

(W/ permission) our incredibly thoughtful VAD patient & her family delivered a true feast to our team yesterday. Done bc she is SO grateful for how far she has come w life on the VAD. This is why we do what we do- empower patients to live fully again! Mandeep R. Mehra, MBBS, MSc, FRCP (London) Michael Givertz

(W/ permission) our incredibly thoughtful VAD patient & her family delivered a true feast to our team yesterday.  Done bc she is SO grateful for how far she has come w life on the VAD.  This is why we do what we do- empower patients to live fully again! @MRMehraMD @GivertzMichael
account_circle
Erin Lyons Matiello(@ErinMatiello) 's Twitter Profile Photo

Team pics from day 2 @ How great is it that our Brigham crew is composed of clinicians from advanced heart failure, infectious dis, hematology, & even surgery (that’s our honorary BWH surgeon Ivan Netuka 😁) MultiD @ its finest Michael Givertz Ann Woolley Mandeep R. Mehra, MBBS, MSc, FRCP (London)

Team pics from day 2 @ #ISHLT2024 How great is it that our Brigham crew is composed of clinicians from advanced heart failure, infectious dis, hematology, & even surgery (that’s our honorary BWH surgeon @netuka_ivan 😁) MultiD @ its finest @GivertzMichael @AnnWoolleyMD @MRMehraMD
account_circle
Erin Lyons Matiello(@ErinMatiello) 's Twitter Profile Photo

My first year @ and I couldn’t be more proud to learn amongst my colleagues & mentors, and of course listen to fantastic discussion re: the relevance of LVAD therapy -let us not “forget” about this valuable support Francesco Castagna Michael Givertz Maya H. Barghash, MD Mandeep R. Mehra, MBBS, MSc, FRCP (London)

My first year @ #THT2024 and I couldn’t be more proud to learn amongst my colleagues & mentors, and of course listen to fantastic discussion re: the relevance of LVAD therapy -let us not “forget” about this valuable support @FraCastagna_MD @GivertzMichael @mayabarghash @MRMehraMD
account_circle
Quin Denfeld, PhD, RN, FAAN, FAHA, FHFSA(@quin_denfeld) 's Twitter Profile Photo

Attn: attendees!

As you build your Saturday schedule, pls ✅ out these informal research chats in the Exhibit Hall:
8-9am: HFRN
1-2pm: AI in HF research
5-6pm: PROs in HF

Come over & chat w/ thought leaders!

Michael Givertz Mitchell Psotka Larisa Tereshchenko, MD, PhD Julie T Bidwell

Attn: #HFSA2023 attendees!

As you build your Saturday schedule, pls ✅ out these informal research chats in the Exhibit Hall:
8-9am: HFRN 
1-2pm: AI in HF research
5-6pm: PROs in HF 

Come over & chat w/ thought leaders!

@GivertzMichael @mpsotka @Tereshchenkolab @BidwellJT
account_circle
HFSA(@HFSA) 's Twitter Profile Photo

Roll call! 👋 If you’re joining the Twitter chat, drop a tweet and introduce yourself! We’re excited to have John R Teerlink, MD Michael Givertz & John Barnes joining us today. 😃

Roll call! 👋 If you’re joining the #HFResearchFDN Twitter chat, drop a tweet and introduce yourself! We’re excited to have @jteerlinkmd @GivertzMichael & @JohnBar27957619  joining us today. 😃
account_circle
HFSA(@HFSA) 's Twitter Profile Photo

Hear from John R Teerlink, MD Michael Givertz @JohnBar2795761 TOMORROW during our Twitter Chat! Join in on the conversation at 4 PM EST and learn more about the Heart Failure Research Foundation and how you can make an impact.

Follow HFSA >> x.com/hfsa

Hear from @jteerlinkmd @GivertzMichael @JohnBar2795761 TOMORROW during our Twitter Chat! Join in on the conversation at 4 PM EST and learn more about the Heart Failure Research Foundation and how you can make an impact.

Follow HFSA >> x.com/hfsa
account_circle
James Schurr, MD, PharmD(@schurr_james) 's Twitter Profile Photo

From our multicenter experience:

1. ECMO bridged patients are sicker than non-bridged IMACS 1 and have worse but acceptable 1yr survival (75% w/ HM3) (should ECMO be IMACS 0?)
2. HM3 recipients had improved survival

Mike Genuardi, MD Michael Givertz
Akram Zaaqoq Katelyn Sylvester

account_circle
JHLT(@TheJHLT) 's Twitter Profile Photo

Analysis using /UNOS data finds that the use of COVID+ donors for heart transplantation is uncommon but increasing over time with similar post-transplant outcomes to those using COVID- donors @ersied727 Kiran Khush Anu Lala-Trindade Michael Givertz

🔗jhltonline.org/article/S1053-…

account_circle